tiprankstipranks
Trending News
More News >
Bioventus (BVS)
NASDAQ:BVS
US Market

Bioventus (BVS) Technical Analysis

Compare
172 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Bioventus’s (BVS) Moving Averages Convergence Divergence (MACD) indicator is -0.13, suggesting Bioventus is a Sell.
Bioventus’s (BVS) 20-Day exponential moving average is 6.66, while Bioventus’s (BVS) share price is $6.35, making it a Sell.
Bioventus’s (BVS) 50-Day exponential moving average is 7.20, while Bioventus’s (BVS) share price is $6.35, making it a Sell.

Bioventus (BVS) Pivot Points

Jun 19, 2025, 10:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.42
6.49
6.55
6.62
6.68
6.75
6.81
Fibonacci
6.49
6.54
6.57
6.62
6.67
6.70
6.75
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bioventus (BVS) Moving Averages

Jun 19, 2025, 10:28 AM
Period
Simple
Exponential
MA5
6.60Sell
6.55Sell
MA10
6.63Sell
6.60Sell
MA20
6.60Sell
6.66Sell
MA50
7.01Sell
7.20Sell
MA100
8.49Sell
8.03Sell
MA200
9.91Sell
8.79Sell
Bioventus’s (BVS) 10-Day exponential moving average is 6.60, while Bioventus’s (BVS) share price is $6.35, making it a Sell.
Bioventus’s (BVS) 100-Day exponential moving average is 8.03, while Bioventus’s (BVS) share price is $6.35, making it a Sell.
Bioventus’s (BVS) stock price is $6.35 and Bioventus’s (BVS) 50-day simple moving average is 7.01, creating a Sell signal.
Bioventus’s (BVS) stock price is $6.35 and Bioventus’s (BVS) 100-day simple moving average is 8.49, creating a Sell signal.
Bioventus’s (BVS) stock price is $6.35 and Bioventus’s (BVS) 200-day simple moving average is 9.91, creating a Sell signal.

Bioventus (BVS) Technical Indicators

Jun 19, 2025, 10:28 AM
Name
Value
Implied Action
RSI (14)
37.63
Neutral
STOCH (9,6)
22.76
Neutral
STOCHRSI (14)
25.55
Neutral
MACD (12,26)
-0.13
Sell
ADX (14)
21.84
Neutral
Williams %R
-97.33
Buy
CCI (14)
-127.09
Buy
ATR (14)
0.30
-
Ultimate Oscillator
35.68
Neutral
ROC
-2.76
Sell
Bioventus’s (BVS) Relative Strength Index (RSI) is 37.63, creating a Neutral signal.
Bioventus’s (BVS) Trend Strength Indicator (ADX) is 21.84, creating a Neutral signal.
Bioventus’s (BVS) Commodity Channel Index (CCI) is -127.09, creating a Buy signal.
Bioventus’s (BVS) Price Rate of Change (ROC) is -2.76, creating a Sell signal.

FAQ

Is BVS a Buy, Hold, or Sell?
Based on BVS’s technical indicators, BVS is a Strong Sell.
    What is BVS’s RSI (14)?
    BVS’s RSI (14) is 37.63, which suggests BVS is a Neutral.
      What is BVS’s MACD?
      BVS’s MACD is -0.13, which suggests BVS is a Sell.
        What is BVS’s 5-day moving average?
        BVS’s 5-day moving average is 6.60, which suggests BVS is a Sell.
          What is BVS’s 20-day moving average?
          BVS 20-day moving average is 6.60, which suggests BVS is a Sell.
            What is BVS’s 50-day moving average?
            BVS’s 50-day moving average is 7.01, which suggests BVS is a Sell.
              What is BVS’s 200-day moving average?
              BVS’s 200-day moving average is 9.91, which suggests BVS is a Sell.
                What is BVS’s Williams % R (14)?
                BVS’s Williams % R (14) is -97.33, which suggests BVS is a Buy.
                  What is BVS’s CCI (14)?
                  BVS’s CCI (14) is -127.09, which suggests BVS is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis